Spire Healthcare Group (LON:SPI) Shares Up 14.1% - Here's Why

Key Points

• Spire Healthcare Group's shares rose by 14.1%, reaching a high of GBX 256.50 ($3.48) during trading, significantly above its previous close of GBX 216.50 ($2.93).
• Analyst ratings show a consensus of "Buy" with a price target averaging GBX 294.33, although JPMorgan Chase & Co. recently adjusted their target down to GBX 303.
• The company reported earnings of GBX 4.10 per share for the latest quarter, with predictions of approximately 15.66 earnings per share for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares shot up 14.1% during mid-day trading on Friday . The company traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). 9,747,062 shares changed hands during trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SPI. JPMorgan Chase & Co. dropped their price objective on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 280 price target on shares of Spire Healthcare Group in a report on Thursday, July 31st. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of GBX 294.33.

Spire Healthcare Group Price Performance

The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The stock has a market capitalization of £947.58 million, a P/E ratio of 5,119.57, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The firm has a 50-day moving average price of GBX 218.99 and a 200 day moving average price of GBX 203.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, analysts expect that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.